LB
31
-2
BAC
72
-2
CMG
61
3
BSX
60
3
CMCSA
46
-10
PCAR
62
-2
KMB
42
-2
HCA
59
-3
AAL
53
2
CL
56
-6
ALLE
41
-5
VIX
32
-12
EXR
24
-4
LH
40
-3
MPC
36
-3
AVY
54
-7
DE
43
-3
TSCO
50
-3
AMP
66
-3
LRCX
71
22
LB
31
-2
BAC
72
-2
CMG
61
3
BSX
60
3
CMCSA
46
-10
PCAR
62
-2
KMB
42
-2
HCA
59
-3
AAL
53
2
CL
56
-6
ALLE
41
-5
VIX
32
-12
EXR
24
-4
LH
40
-3
MPC
36
-3
AVY
54
-7
DE
43
-3
TSCO
50
-3
AMP
66
-3
LRCX
71
22
Financhill
Back

Freeport-McMoRan, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Buy
72

FCX
Freeport-McMoRan, Inc.

Last Price:
$49.13
Seasonality Move:
7.92%
Buy
78

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Buy
72
Freeport-McMoRan, Inc. (FCX) is a Buy

Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?

  • The current Freeport-McMoRan, Inc. [FCX] share price is $47.92. The Score for FCX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.35. The Score for CDTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FCX Stock Price Chart

What is Freeport-McMoRan, Inc.'s stock price today?

  • The Freeport-McMoRan, Inc. share price today is $47.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.77 Buy
Relative Strength Index (14 RSI): 71.08 Buy
Chaikin Money Flow: 3468354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.6 - 46.62) Buy
Bollinger Bands (100): (39.69 - 45.07) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.79 Buy
Relative Strength Index (14 RSI): 84.87 Buy
Chaikin Money Flow: 261741 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (192.91 - 237.53) Buy
Bollinger Bands (100): (54.69 - 176.45) Buy

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.19 Buy
20-day SMA: 44.47 Buy
50-day SMA: 42.44 Buy
200-day SMA: 40.98 Buy
8-day EMA: 47.04 Buy
20-day EMA: 45.17 Buy
50-day EMA: 43.35 Buy
200-day EMA: 42 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.19 Buy
20-day SMA: 220.08 Buy
50-day SMA: 159.67 Buy
200-day SMA: 72.77 Buy
8-day EMA: 219.95 Buy
20-day EMA: 209.45 Buy
50-day EMA: 171.39 Buy
200-day EMA: 93.26 Buy

Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.73 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Freeport-McMoRan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):